References

Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021

10.1016/s2665-9913(23)00163-7 · 2023 · External reference

Epidemiology of osteoarthritis

10.1016/j.joca.2021.04.020 · 2022 · External reference

Mitochondrial-ER stress crosstalk in osteoarthritis: From ageing-associated chondrocyte dysfunction to emerging therapeutics

10.1016/j.arr.2026.103252 · 2026 · External reference

Osteoarthritis: Epidemiology, diagnosis, and treatment

10.1002/mco2.70834 · 2026 · External reference

Advances in heterogeneity and classification of osteoarthritis

10.1038/s41413-026-00549-x · 2026 · External reference

Synovitis in osteoarthritis: current understanding with therapeutic implications

10.1186/s13075-017-1229-9 · 2017 · External reference

iMSC-derived extracellular vesicles and their miRNA cargo influence inflammation and oxidative damage in an in vitro osteoarthritis model

10.1038/s41419-026-09033-0 · 2026 · External reference

Skeletal muscle\‑derived extracellular vesicles in multi‑organ degenerative disease: Mechanisms and therapeutic delivery perspectives (Review)

10.3892/ijmm.2026.5903 · 2026 · External reference

Systemic implications of osteoarthritis: from local degeneration to systemic metabolic dysregulation

10.1186/s12967-026-08277-w · 2026 · External reference

Mammalian, plant, and gut microbiota-derived extracellular vesicles as emerging therapeutics for bone diseases

10.3389/fbioe.2026.1825617 · 2026 · External reference

Mesenchymal stem cell-derived exosomes and their therapeutic potential for osteoarthritis

10.3390/biology10040285 · 2021 · External reference

Cartilage repair by mesenchymal stem cell-derived exosomes: Preclinical and clinical trial update and perspectives

10.1007/5584_2021_625 · 2021 · External reference

Mesenchymal stem cell therapy in osteoarthritis and rheumatoid arthritis: A systematic review of exosomal microRNAs

10.2147/btt.s571417 · 2025 · External reference

Changes in stiffness and biochemical composition of the pericellular matrix as a function of spatial chondrocyte organisation in osteoarthritic cartilage

10.1016/j.joca.2019.01.008 · 2019 · External reference

Current status and future perspectives of research on intra-articular drug delivery systems for osteoarthritis therapy

10.1016/j.actbio.2025.07.057 · 2025 · External reference

Intra-articular drug delivery systems for osteoarthritis therapy: shifting from sustained release to enhancing penetration into cartilage

10.1080/10717544.2022.2048130 · 2022 · External reference

Nanomedicines targeting matrix metalloproteinases for osteoarthritis treatment

10.1016/j.ijpharm.2026.127064 · 2026 · External reference

Design strategies of biomaterial-based intra-articular drug delivery system for osteoarthritis therapy

10.1016/j.jconrel.2025.114496 · 2026 · External reference

Proteolysis of the pericellular matrix: Pinpointing the role and involvement of matrix metalloproteinases in early osteoarthritic remodeling

10.1016/j.actbio.2024.05.002 · 2024 · External reference

Smart nanodelivery systems for immunometabolic modulation in osteoarthritis

10.1002/exp2.70185 · 2026 · External reference

Exosomes from IL-1β stimulated synovial fibroblasts induce osteoarthritic changes in articular chondrocytes

10.1186/ar4679 · 2014 · External reference

MSC exosomes mediate cartilage repair by enhancing proliferation, attenuating apoptosis and modulating immune reactivity

10.1016/j.biomaterials.2017.11.028 · 2018 · External reference

Investigation into the collection and isolation workflows of extracellular vesicles from tears

10.1002/jex2.70158 · 2026 · External reference

Tissue derived extracellular vesicles advance from disease mechanisms to clinical application

10.1186/s11671-026-04785-2 · 2026 · External reference

MSC-derived extracellular vesicles accelerate wound healing in senescent fibroblast cultures

10.1007/s10522-026-10468-3 · 2026 · External reference

Systemic health impact of cancer-associated extracellular vesicles and particles

10.1038/s41568-026-00952-w · 2026 · External reference

Extracellular vesicles and particles impact the systemic landscape of cancer

10.15252/embj.2021109288 · 2022 · External reference

Beyond M1/M2: The pivotal role of macrophage metabolic reprogramming in chronic bone disease and targeted intervention

10.3390/ijms27093731 · 2026 · External reference

Exosomes maintain cellular homeostasis by excreting harmful DNA from cells

10.1038/ncomms15287 · 2017 · External reference

Small extracellular vesicles derived from synovial fibroblasts contain distinct miRNA profiles and contribute to chondrocyte damage in osteoarthritis

10.1186/s13075-024-03398-3 · 2024 · External reference

Comparative analysis of the therapeutic potential of extracellular vesicles secreted by aged and young bone marrow-derived mesenchymal stem cells in osteoarthritis pathogenesis

10.1111/cpr.13776 · 2025 · External reference

Extracellular vesicles from senescent mesenchymal stromal cells are defective and cannot prevent osteoarthritis

10.1186/s12951-024-02509-1 · 2024 · External reference

Hypoxic pretreatment of small extracellular vesicles mediates cartilage repair in osteoarthritis by delivering miR-216a-5p

10.1016/j.actbio.2020.12.034 · 2021 · External reference

Inflammatory fibroblast-like synoviocyte-derived exosomes aggravate osteoarthritis via enhancing macrophage glycolysis

10.1002/advs.202307338 · 2024 · External reference

Adipose mesenchymal stem cells derived exosomes ameliorates KOA cartilage damage and inflammation by activation of PINK1-mediated mitochondrial autophagy

10.21203/rs.3.rs-4554294/v1 · 2025 · External reference

A comparative study on the effect of exosomes secreted by mesenchymal stem cells derived from adipose and bone marrow tissues in the treatment of osteoarthritis-induced mouse model

10.1155/2021/9688138 · 2021 · External reference

Injectable hyperbranched PEG crosslinked hyaluronan hydrogel microparticles containing mir-99a-3p modified subcutaneous ADSCs-derived exosomes was beneficial for long-term treatment of osteoarthritis

10.1016/j.mtbio.2023.100813 · 2023 · External reference

Stem cell and cell-free strategies for osteoarthritis: Toward durable regenerative therapies

10.1155/sci/6699734 · 2026 · External reference

Mechanosensitive miRNAs in cartilage and subchondral bone remodeling: Emerging targets for osteoarthritis therapy

10.2147/jir.s529149 · 2025 · External reference

Osteocyte-derived extracellular vesicles mediate the bone-to-cartilage crosstalk and promote osteoarthritis progression

10.1038/s41467-025-59861-5 · 2025 · External reference

Enhanced exosome biomanufacturing, precision isolation, and advanced engineering: toward mechanistic regulation and biomaterial integration for osteoarthritis therapy

10.1186/s12951-026-04710-w · 2026 · External reference

Spatial distribution of extracellular vesicles, autofluorescence and CD9 positivity around chondrocytes in the superficial layer of articular cartilage

10.1002/jev2.70183 · 2025 · External reference

Advancing osteoarthritis treatment: The therapeutic potential of mesenchymal stem cell-derived exosomes and biomaterial integration

10.3390/biomedicines12112478 · 2024 · External reference

Gender-specific differential expression of exosomal miRNA in synovial fluid of patients with osteoarthritis

10.1038/s41598-017-01905-y · 2017 · External reference

Identification of exosomal mRNA, lncRNA and circRNA signatures in an osteoarthritis synovial fluid-exosomal study

10.1016/j.yexcr.2021.112881 · 2022 · External reference

Therapeutic extracellular vesicles from synovial fibroblast-primed MSCs for osteoarthritis treatment

10.1002/adhm.71406 · 2026 · External reference

Synovial fibroblast extracellular vesicles induce inflammation via delivering miR-21-5p in osteoarthritis

10.3390/cells14070519 · 2025 · External reference

M2-sEVs-based immunotherapy for alleviation of osteoarthritis-related pain by regulating synovial macrophage NGF expression via the NOTCH pathway

10.1080/17435889.2026.2623975 · 2026 · External reference

NsPEFs-enriched ADSCs-EVs alleviate osteoarthritis via RSPO3-mediated dual pro-chondrogenic and pro-M2 macrophage properties

10.1016/j.bioactmat.2026.01.006 · 2026 · External reference

Synovial inflammatory macrophage-derived extracellular vesicles exacerbate cartilage lesions with a FMRP-selectively sorted manner in osteoarthritis

10.1038/s41413-025-00502-4 · 2026 · External reference

Exosomes in aging and age-related disorders: mechanisms, therapeutic potentials, and challenges

10.1186/s12967-025-07379-1 · 2025 · External reference

Hybrid extracellular vesicles drive irreversible mitochondria damage and TCA metabolite deficiency-related chondrocyte senescence

10.1016/j.xinn.2025.101247 · 2026 · External reference

Cellular senescence in skeletal diseases: a bibliometric analysis from 2007 to 2024

10.1016/j.exger.2025.112857 · 2025 · External reference

Exosomal miR-95-5p regulates chondrogenesis and cartilage degradation via histone deacetylase 2/8

10.1111/jcmm.13808 · 2018 · External reference

Extracellular vesicles in bone aging: therapeutic strategies and applications

10.20517/evcna.2025.58 · 2025 · External reference

Targeting the senescence-associated secretory phenotype to modify osteoarthritis in aging

10.1007/s10787-025-02001-8 · 2025 · External reference

Exosomes in Osteoarthritis: Emerging Roles in Pathogenesis, Diagnosis, and Therapeutic Potential

10.2174/0113816128412201251125100451 · 2026 · External reference

Platelet-Derived Components for Skin and Bone Aging and Age-Associated Pathologies: Mechanisms, Bioengineering Strategies, and Clinical Translation

10.3390/molecules31050867 · 2026 · External reference

Extracellular vesicles from human adipose-derived stem cells relieve pain and inflammation in a rat model of knee osteoarthritis

10.1186/s13287-026-04932-7 · 2026 · External reference

Exosomes Derived from Hypoxia-Cultured Human Adipose Stem Cells Alleviate Articular Chondrocyte Inflammaging and Post-Traumatic Osteoarthritis Progression

10.3390/ijms241713414 · 2023 · External reference

FTO-overexpressing extracellular vesicles from BM-MSCs reverse cellular senescence and aging to ameliorate osteoarthritis by modulating METTL3/YTHDF2-mediated RNA m6A modifications

10.1016/j.ijbiomac.2024.134600 · 2024 · External reference

Extracellular Vesicles in Osteoarthritis: From Pathogenic Mediators to Engineered Therapeutics in a Precision Medicine Roadmap

10.1002/jex2.70131 · 2026 · External reference

Vascular endothelial cell-secreted exosomes facilitate osteoarthritis pathogenesis by promoting chondrocyte apoptosis

10.18632/aging.202506 · 2021 · External reference

The Infrapatellar Fat Pad in Osteoarthritis: From Pathophysiology to a Novel Therapeutic Target

10.3390/ijms27052369 · 2026 · External reference

Functional Assessment of Genetically Modified Infrapatellar Fat Pad Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles (EVs): Potential Implications for Inflammation/Pain Reversal in Osteoarthritis

10.3390/cells14241952 · 2025 · External reference

Apoptotic extracellular vesicles act as master regulators of the bone healing niche

10.1186/s12951-026-04351-z · 2026 · External reference

Decoding the therapeutic potential of extracellular vesicles in osteoarthritis: from biomolecular composition to clinical translation

10.1097/js9.0000000000003219 · 2025 · External reference

Apoptotic extracellular vesicles: unveiling mechanisms, diverse functions, and biomedical implications

10.1007/s10495-026-02295-1 · 2026 · External reference

Bibliometric and LDA analysis of extracellular vesicles in osteoarthritis

10.1038/s41413-025-00484-3 · 2025 · External reference

Exosomal Interventions in Bone and Osteochondral Repair: Mechanisms and Outcomes

10.3390/ijms262211172 · 2025 · External reference

Mesenchymal stem cells and extracellular vesicles for knee osteoarthritis: clinical application, mechanism exploration and prospect

10.1186/s13287-025-04783-8 · 2025 · External reference

The crosstalk among macrophages, chondrocytes and mesenchymal stem cells in osteoarthritis: the role of extracellular vesicles

10.1186/s13287-025-04659-x · 2025 · External reference

Mesenchymal stem cells derived exosomes and microparticles protect cartilage and bone from degradation in osteoarthritis

10.1038/s41598-017-15376-8 · 2017 · External reference

Macrophage: A Potential Target on Cartilage Regeneration

10.3389/fimmu.2020.00111 · 2020 · External reference

Macrophages-derived small extracellular vesicles regulate chondrocyte proliferation and affect osteoarthritis progression via upregulating Osteopontin expression

10.1002/ccs3.70008 · 2025 · External reference

Extracellular vesicles in osteoarthritis: mechanisms, therapeutic potential, and diagnostic applications

10.3389/fimmu.2025.1595095 · 2025 · External reference

BMSC-derived exosomal miR-27a-3p ameliorates osteoarthritis via dual regulation of chondrocyte protection and macrophage M1 polarization through TXNIP/NLRP3 signaling

10.1016/j.abb.2026.110902 · 2026 · External reference

New mesenchymal stem/stromal cell-based strategies for osteoarthritis treatment: targeting macrophage-mediated inflammation to restore joint homeostasis

10.1007/s00109-025-02547-8 · 2025 · External reference

Exosomes derived from umbilical cord mesenchymal stem cells protect cartilage and regulate the polarization of macrophages in osteoarthritis

10.21037/atm-22-3912 · 2022 · External reference

BMP-7 modified exosomes derived from synovial mesenchymal stem cells attenuate osteoarthritis by M2 polarization of macrophages

10.1016/j.heliyon.2023.e19934 · 2023 · External reference

The therapeutic potential of adiponectin and extracellular vesicles for promoting improved healthspan

10.1016/j.arr.2025.102823 · 2025 · External reference

Biomaterial Strategies in Osteoarthritis: New Insights Bridging Aging Phenotypes and Hypoxic Microenvironment Pathology

10.1002/adhm.202501570 · 2025 · External reference

Progress in antisenescence biomaterials for improved osteoarthritis therapy

10.1016/j.actbio.2025.08.044 · 2025 · External reference

Immunoregulatory orchestrations in osteoarthritis and mesenchymal stromal cells for therapy

10.1016/j.jot.2025.08.009 · 2025 · External reference

Engineered MSC-sEVs as a Versatile Nanoplatform for Enhanced Osteoarthritis Treatment via Targeted Elimination of Senescent Chondrocytes and Maintenance of Cartilage Matrix Metabolic Homeostasis

10.1002/advs.202413759 · 2025 · External reference

Circulating Metabolites Treat Human TMJ-OA by Eliminating Senescent Chondrocytes via the C1QBP/C1q/p14ARF Axis

10.2139/ssrn.5391649 · 2026 · External reference

Engineered Extracellular Vesicles in Arthritic Diseases: Therapeutic Applications & Challenges

10.1002/wnan.70031 · 2025 · External reference

Targeting osteoarthritis with small extracellular vesicle therapy: potential and perspectives

10.3389/fbioe.2025.1570526 · 2025 · External reference

Regulatory Challenges and Opportunities for Cell-Derived Extracellular Vesicles in Pharmaceutical Development: A European and Global Perspective

10.1002/jev2.70332 · 2026 · External reference

Comparison of the ability of exosomes and ectosomes derived from adipose-derived stromal cells to promote cartilage regeneration in a rat osteochondral defect model

10.1186/s13287-024-03632-4 · 2024 · External reference

Exosomes derived from umbilical cord mesenchymal stem cells in mechanical environment show improved osteochondral activity via upregulation of LncRNA H19

10.1016/j.jot.2020.03.005 · 2021 · External reference

Mechanical loading primes MSC-derived exosomes to promote cartilage repair

10.1016/j.bioactmat.2026.06.023 · 2026 · External reference

Chondroprotective effects of bone marrow mesenchymal stem cell-derived exosomes in osteoarthritis

10.1007/s10863-023-09991-6 · 2024 · External reference

Exosome modification to better alleviates endoplasmic reticulum stress induced chondrocyte apoptosis and osteoarthritis

10.1016/j.bcp.2022.115343 · 2022 · External reference

Exosomal miR-429 derived from adipose-derived stem cells ameliorated chondral injury in osteoarthritis via autophagy by targeting FEZ2

10.1016/j.intimp.2023.110315 · 2023 · External reference

Exosomes derived from miR-140-5p-overexpressing human synovial mesenchymal stem cells enhance cartilage tissue regeneration and prevent osteoarthritis of the knee in a rat model

10.7150/thno.17133 · 2017 · External reference

miR-100-5p-abundant exosomes derived from infrapatellar fat pad MSCs protect articular cartilage and ameliorate gait abnormalities via inhibition of mTOR in osteoarthritis

10.1016/j.biomaterials.2019.03.022 · 2019 · External reference

Extracellular vesicles derived from human umbilical cord mesenchymal stem cells alleviate osteoarthritis of the knee in mice model by interacting with METTL3 to reduce m6A of NLRP3 in macrophage

10.1186/s13287-022-03005-9 · 2022 · External reference

Clinical-grade extracellular vesicles derived from umbilical cord mesenchymal stromal cells: preclinical development and first-in-human intra-articular validation as therapeutics for knee osteoarthritis

10.1186/s12951-024-03088-x · 2025 · External reference

Therapeutic efficacy of extracellular vesicles from hiPSC-derived MSCs in serum-containing and xeno-free media for osteoarthritis treatment

10.1186/s13287-025-04890-6 · 2026 · External reference

M2 macrophage-derived extracellular vesicles encapsulated in hyaluronic acid alleviate osteoarthritis by modulating macrophage polarization

10.1021/acsbiomaterials.3c01833 · 2024 · External reference

Exosomes and small extracellular vesicles as an alternative to mesenchymal stromal cell therapy in knee osteoarthritis: From biological rationale to clinical evidence

10.3390/ijms27093737 · 2026 · External reference

Functional nucleic acid hydrogels: Paving the way for next-generation bone and cartilage regeneration

10.1016/j.mtbio.2025.102708 · 2026 · External reference

MSC-derived exosomes promote proliferation and inhibit apoptosis of chondrocytes via lncRNA-KLF3-AS1/miR-206/GIT1 axis in osteoarthritis

10.1080/15384101.2018.1526603 · 2018 · External reference

Mesenchymal stem cell-derived exosome mediated long non-coding RNA KLF3-AS1 represses autophagy and apoptosis of chondrocytes in osteoarthritis

10.1080/15384101.2021.2019411 · 2022 · External reference

Bio-nanoparticles loaded with synovial-derived exosomes ameliorate osteoarthritis progression by modifying the oxidative microenvironment

10.1186/s12951-024-02538-w · 2024 · External reference

Mitochondrial transplantation for osteoarthritis: From molecular mechanisms to clinical translation

10.3389/fimmu.2026.1716906 · 2026 · External reference

Extracellular vesicles from IPFP-MSCs trigger osteoarthritis by transferring mtDNA

10.1016/j.bioactmat.2025.11.046 · 2026 · External reference

ESC-sEVs alleviate non-early-stage osteoarthritis progression by rejuvenating senescent chondrocytes via FOXO1A-autophagy axis but not inducing apoptosis

10.1016/j.phrs.2024.107474 · 2024 · External reference

Autophagic LC3(+) calcified extracellular vesicles initiate cartilage calcification in osteoarthritis

10.1126/sciadv.abn1556 · 2022 · External reference

Extracellular vesicles and autophagy in osteoarthritis

10.1155/2016/2428915 · 2016 · External reference

Engineering exosomes derived from subcutaneous fat MSCs specially promote cartilage repair as miR-199a-3p delivery vehicles in osteoarthritis

10.1186/s12951-023-02086-9 · 2023 · External reference

Unveiling the potential of MSC extracellular vesicles: MiR-122-5p enhancing chondrocyte regeneration in osteoarthritis via autophagy mechanism

10.1186/s13287-025-04412-4 · 2025 · External reference

A synergistic strategy involving reverse-adaptation and engineered MSC exosomes against ferroptosis in osteoarthritis

10.1016/j.biomaterials.2026.124024 · 2026 · External reference

Mapping the landscape of mesenchymal stem cell-derived extracellular vesicles: From bench to bedside

10.1155/sci/5361754 · 2025 · External reference

Bridging osteoimmunology and regenerative therapy: The role of MSCs and extracellular vesicles

10.3390/ijms27031155 · 2026 · External reference

Engineered exosome biomedical technologies for precision diagnosis and therapy in orthopedic diseases

10.3389/fmed.2026.1788658 · 2026 · External reference

Research landscape of nanomaterials in osteoarthritis: A bibliometric and knowledge mapping analysis

10.1177/19373368261419658 · 2026 · External reference

Current status and future prospects of nanocarrier-mediated miRNA delivery for osteoarthritis therapy

10.3389/fmed.2025.1728944 · 2025 · External reference

Surface functionalization of exosomes for chondrocyte-targeted siRNA delivery and cartilage regeneration

10.1016/j.jconrel.2024.04.009 · 2024 · External reference

Chondrocyte-targeted delivery system of sortase A-engineered extracellular vesicles silencing MMP13 for osteoarthritis therapy

10.1002/adhm.202303510 · 2024 · External reference

Mechanisms and therapeutic potential of stem cell-derived extracellular vesicles as nanocarriers in musculoskeletal disorders

10.1002/biot.70172 · 2026 · External reference

Reversing the surface charge of MSC-derived small extracellular vesicles by ϵPL-PEG-DSPE for enhanced osteoarthritis treatment

10.1002/jev2.12160 · 2021 · External reference

Cartilage-targeting exosomes for delivery of receptor antagonist of interleukin-1 in osteoarthritis treatment

10.1016/j.joca.2025.02.785 · 2025 · External reference

Chondrocyte-targeted microRNA delivery by engineered exosomes toward a cell-free osteoarthritis therapy

10.1021/acsami.0c10458 · 2020 · External reference

Extracellular vesicle-integrated biomaterials in bone tissue engineering applications: Current progress and future perspectives

10.2147/ijn.s522198 · 2025 · External reference

Interfacing extracellular vesicles with bioengineered materials for regenerative medicine

10.1016/j.actbio.2025.10.022 · 2025 · External reference

Bone mesenchymal stem cell-derived exosomes involved co-delivery and synergism effect with icariin via mussel-inspired multifunctional hydrogel for cartilage protection

10.1016/j.ajps.2023.100799 · 2023 · External reference

Engineering extracellular vesicles as nanotherapeutics for regenerative medicine

10.3390/biom10010048 · 2019 · External reference

Extracellular vesicles for tissue repair and regeneration: Evidence, challenges and opportunities

10.1016/j.addr.2021.04.013 · 2021 · External reference

Methods and strategies of bioengineered cell exosomes for the treatment of osteoarthritis

10.1016/j.jbspin.2025.106030 · 2026 · External reference

Minimum information for studies of extracellular vesicles (MISEV) as toolbox for rigorous, reproducible and homogeneous studies on extracellular vesicles

10.1016/j.tiv.2025.106049 · 2025 · External reference

The impact of storage on extracellular vesicles: A systematic study

10.1002/jev2.12162 · 2022 · External reference

Preservation of small extracellular vesicles for functional analysis and therapeutic applications: A comparative evaluation of storage conditions

10.1080/10717544.2020.1869866 · 2021 · External reference

Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesicles

10.1016/j.jcyt.2021.01.001 · 2021 · External reference

Functional extracellular vesicles for regenerative medicine

10.1002/smll.202106569 · 2022 · External reference

Immunogenicity of extracellular vesicles

10.1002/adma.202403199 · 2024 · External reference

Procoagulant properties of mesenchymal stem cells and extracellular vesicles: A novel aspect of thrombosis pathogenesis

10.1093/stmcls/sxad087 · 2024 · External reference

Biodistribution of therapeutic extracellular vesicles

10.20517/evcna.2023.12 · 2023 · External reference

Safety and efficacy of placental mesenchymal stromal cells-derived extracellular vesicles in knee osteoarthritis: A randomized, triple-blind, placebo-controlled clinical trial

10.1186/s12891-024-07979-w · 2024 · External reference

Injection of human umbilical cord mesenchymal stem cells exosomes for the treatment of knee osteoarthritis: From preclinical to clinical research

10.1186/s12967-025-06623-y · 2025 · External reference

Umbilical cord-derived Wharton's jelly for treatment of knee osteoarthritis: Study protocol for a non-randomized, open-label, multi-center trial

10.1186/s13018-021-02300-0 · 2021 · External reference

Cell-free stem cell-derived extract formulation for treatment of knee osteoarthritis: Study protocol for a preliminary non-randomized, open-label, multi-center feasibility and safety study

10.1186/s13018-021-02672-3 · 2021 · External reference

Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

10.1080/20013078.2018.1535750 · 2018 · External reference

Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

10.1002/jev2.12404 · 2024 · External reference

Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes

10.1073/pnas.1521230113 · 2016 · External reference

Improving reproducibility to meet minimal information for studies of extracellular vesicles 2018 guidelines in nanoparticle tracking analysis

10.3791/63059 · 2021 · External reference

Comparison of matrix vesicles derived from normal and osteoarthritic human articular cartilage

10.3109/03008209609029209 · 1996 · External reference

Human osteoarthritic cartilage matrix vesicles generate both calcium pyrophosphate dihydrate and apatite in vitro

10.1007/s002239900523 · 1998 · External reference

Engineered MSC-exosomes delivering miRNAs for respiratory disease diagnostics and therapy: Opportunities and challenges

10.2147/ijn.s560737 · 2026 · External reference

Endocytosis of extracellular vesicles and release of their cargo from endosomes

10.1021/acsnano.9b10033 · 2020 · External reference

Endosomal escape of nucleic acids from extracellular vesicles mediates functional therapeutic delivery

10.1016/j.phrs.2023.106665 · 2023 · External reference

CD63 sorts cholesterol into endosomes for storage and distribution via exosomes

10.1038/s41556-024-01432-9 · 2024 · External reference

Equine osteoarthritis modifies fatty acid signatures in synovial fluid and its extracellular vesicles

10.1186/s13075-023-02998-9 · 2023 · External reference

Proteome and phospholipidome interrelationship of synovial fluid-derived extracellular vesicles in equine osteoarthritis: An exploratory 'multi-omics' study to identify composite biomarkers

10.1016/j.bbrep.2023.101635 · 2024 · External reference

OARSI osteoarthritis cartilage histopathology assessment system: A biomechanical evaluation in the human knee

10.1002/jor.23010 · 2016 · External reference

Degeneration dependent changes in human knee cartilage mechanical properties revealed by synchrotron tomography based finite element modeling

10.1016/j.ocarto.2026.100825 · 2026 · External reference

A review of translational animal models for knee osteoarthritis

10.1155/2012/764621 · 2012 · External reference

OA foundations - experimental models of osteoarthritis

10.1016/j.joca.2021.03.024 · 2022 · External reference

The utility of animal models in understanding osteoarthritis (OA) pathogenesis - an update on the impact of genetically modified mice

10.1302/2046-3758.118.bjr-2022-0217.r1 · 2025 · External reference

A missed opportunity: A scoping review of the effect of sex and age on osteoarthritis using large animal models

10.1016/j.joca.2024.02.009 · 2024 · External reference

Knee osteoarthritis phenotypes and their relevance for outcomes: a systematic review

10.1016/j.joca.2017.02.104 · 2017 · External reference

Immune system-related plasma pathogenic extracellular vesicle subpopulations predict osteoarthritis progression

10.3390/ijms252312504 · 2024 · External reference

Macrophage membrane-coated nanoparticles in inflammatory diseases: from bioinspired design to translational potential

10.1186/s12951-025-03921-x · 2025 · External reference